← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Epoetina beta currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: EPOETINA BETA · data refreshed 8 September 2026
As of 8 September 2026, 1 of the 9 tracked registers list current availability issues for Epoetina beta, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2025-07-07 and has now been open for about 14 months. Where agencies state a cause, manufacturing problems lead with 5 of the 5 stated-cause reports. The furthest expected-resolution date currently on file is 2027-06-30; the earliest is 2027-06-30. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage NEORECORMON + 4 more productsNEORECORMON NEORECORMON NEORECORMON NEORECORMON | 2025-07-07 | 2027-06-30 | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Epoetina beta in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | NEORECORMON | Shortage | 2025-09-29 | 2027-06-30 | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | NEORECORMON | Shortage | 2025-09-08 | 2027-06-30 | Problemi produttivi |
| 🇮🇹 IT | NEORECORMON | Shortage | 2025-08-18 | 2027-06-30 | Problemi produttivi |
| 🇮🇹 IT | NEORECORMON | Shortage | 2025-07-21 | 2027-06-30 | Problemi produttivi |
| 🇮🇹 IT | NEORECORMON | Shortage | 2025-07-07 | 2027-06-30 | Problemi produttivi |
Yes. As of 8 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2027-06-30 to 2027-06-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Epoetina beta: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Epoetina beta — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/epoetina-beta/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Epoetina beta availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/epoetina-beta/">Epoetina beta shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>